Post-Traumatic Stress Disorder (PTSD)

What Healing TMS Clinic offers for PTSD: evidence-based psychiatric medication management. TMS therapy is not currently offered for PTSD at our clinic. Patients seeking trauma-focused psychotherapy (CBT-trauma, prolonged exposure, EMDR) are referred to specialty PTSD therapists. Please confirm your specific treatment plan with your treating clinician at consultation.

Post-traumatic stress disorder is a trauma- and stressor-related disorder that develops following exposure to actual or threatened death, serious injury, or sexual violence — whether directly experienced, witnessed, learned of in a close family member or friend, or encountered through repeated occupational exposure.¹ The DSM-5-TR places PTSD in its own diagnostic chapter and requires symptoms from four clusters — intrusion, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity — persisting longer than one month with clinically significant distress or impairment. Lifetime prevalence in U.S. adults is approximately 6.8%, with twelve-month prevalence near 3.5%; rates are substantially higher among veterans, first responders, and survivors of interpersonal violence.²

Recognized signs and symptoms

Intrusion

• Recurrent intrusive memories, distressing dreams, or dissociative reactions (flashbacks)
• Intense psychological distress or physiological reactivity to trauma cues

Avoidance

• Effortful avoidance of trauma-related thoughts, feelings, conversations, places, or people

Negative alterations in cognition and mood

• Persistent negative beliefs about self, others, or the world
• Distorted blame, persistent fear, horror, anger, guilt, or shame
• Anhedonia, detachment, inability to experience positive emotions

Arousal and reactivity

• Irritability or angry outbursts, reckless behavior
• Hypervigilance, exaggerated startle, concentration difficulty
• Sleep disturbance

Diagnostic criteria

The DSM-5-TR requires a Criterion A trauma exposure plus a defined number of symptoms across each of the four symptom clusters, duration >1 month, and exclusion of substance or medical cause.¹ The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) is the reference-standard diagnostic instrument; the PCL-5 is the most widely used patient-reported severity measure. The 2023 VA/DoD Clinical Practice Guideline for PTSD specifies diagnostic and treatment standards in detail and is the reference our clinicians follow alongside DSM-5-TR.³ This page is educational and not a tool for self-diagnosis.

Treatment options at Healing TMS Clinic

First-line treatment for PTSD per the 2023 VA/DoD Clinical Practice Guideline is trauma-focused psychotherapy, with pharmacotherapy as a secondary or adjunctive option.³

• Trauma-focused psychotherapy (first-line) — Prolonged Exposure (PE),⁴ Cognitive Processing Therapy (CPT), and Eye Movement Desensitization and Reprocessing (EMDR) carry the strongest evidence and are recommended over medication when available. Referred through our vetted clinician network.
• Medication management — SSRIs (sertraline and paroxetine carry FDA approval for PTSD) and the SNRI venlafaxine are evidence-based pharmacotherapy options. Prazosin is used adjunctively for trauma-related nightmares.
• TMS Therapy — repetitive TMS for PTSD is investigational and not currently FDA-cleared as a stand-alone PTSD indication. A growing body of randomized evidence suggests benefit, particularly when PTSD co-occurs with major depressive disorder — the FDA-cleared indication TMS addresses directly.⁵ For patients with comorbid TRD, TMS is a covered, evidence-based option.

When to consider TMS Therapy

For pure PTSD without a depressive disorder, trauma-focused psychotherapy is first-line and TMS is not FDA-cleared. TMS is appropriate to consider for patients with PTSD when:

• There is a comorbid major depressive disorder meeting criteria for treatment-resistant depression (≥2 failed antidepressant trials at adequate dose and duration) — TMS is FDA-cleared for this MDD indication⁶
• Trauma-focused psychotherapy has been offered and either declined, not tolerated, or not available
• No personal history of seizure disorder and no ferromagnetic implants near the treatment coil
• The patient is medically stable for an outpatient course

Patients whose PTSD is the primary diagnosis without depression are typically best served by PE, CPT, or EMDR with an SSRI as appropriate. See TMS Therapy for full mechanism, protocol, and safety detail.

Insurance and TMS for PTSD

Because TMS is not FDA-cleared for PTSD as a stand-alone indication, commercial and Medicare coverage for TMS in PTSD without comorbid TRD is generally not available. When TMS is indicated for comorbid treatment-resistant depression in a patient who also has PTSD, the same TRD coverage pathway applies — documentation of ≥2 failed antidepressant trials at adequate dose and duration, severity confirmation, and prior authorization.

Trauma-focused psychotherapy and FDA-approved PTSD pharmacotherapy are covered by most major carriers and Medicare under standard mental-health benefits. Our team verifies benefits across services. Submit your insurance details through our verification form and we will confirm what is and is not covered for your specific clinical picture.

What to expect at your consultation

The initial visit is a structured psychiatric evaluation that confirms diagnosis using DSM-5-TR criteria, screens for comorbid depression and substance use, and outlines a treatment plan aligned with the VA/DoD guideline. We serve patients across Anaheim, Orange County, and the broader 30-mile service area. Schedule a consultation to begin.

References